Search results
REGENXBIO (NASDAQ:RGNX) adds US$111m to market cap in the past 7 days, though investors from five...
Simply Wall St. via Yahoo Finance· 6 months agoREGENXBIO Inc. (NASDAQ:RGNX) shareholders should be happy to see the share price up 16% in the last...
REGENXBIO's (RGNX) Hunter Syndrome Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 3 months agoREGENXBIO (RGNX) gains 12% on positive top-line results from the phase I/II/III study of its...
Even after rising 26% this past week, REGENXBIO (NASDAQ:RGNX) shareholders are still down 48% over...
Simply Wall St. via Yahoo Finance· 2 years agoThis month, we saw the REGENXBIO Inc. (NASDAQ:RGNX) up an impressive 31%. But that cannot eclipse...
REGENXBIO (RGNX) Soars 15% on Interim Data From DMD Study
Zacks via Yahoo Finance· 2 months agoData from an early-stage study shows that treatment with REGENXBIO's (RGNX) investigational Duchenne...